KO vs RAPP · P/E 25, rev $47.94B vs $532.9M cap
The Coca-Cola Company (KO) versus Rapport Therapeutics, Inc. Common Stock (RAPP) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
RAPP does not have a complete income-statement cache yet.
KO currently screens at market cap $343.90B and trailing P/E 25.1. RAPP currently screens at market cap $532.9M.
Not investment advice. Open the KO and RAPP stock pages for the full models.
Not investment advice.